HomeAI · summaries
Storia in 9 fonti
Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows
An experimental Alzheimer's drug from Biogen, one with a novel approach, slowed decline at comparable rates as approved drugs in a mid-stage study.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
The study provides the clearest evidence yet that medicines like BIIB080 might improve cognition, but leaves unclear why higher doses didn’t perform better.
- ·
apnews.com
An experimental Alzheimer's drug shows some promise as researchers hunt new approaches
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.
